| The pattern of adverse event reporting of dopamine agonists (DAs) in Australia was previously unknown. |
| Ergot DAs shared fibrotic reactions as a class adverse effect (AE), whereas symptomatic hypotensive reactions, psychosis and obsessive-compulsive behaviours occurred in both ergot and non-ergot DAs. |
| Exploring the temporal relationship between post-marketing AE reporting and utilisation data can be a valuable pharmacovigilance tool to encourage targeted adverse event monitoring and reporting. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.